Doxorubicin and haemoglobin decreased Patient Reports February 11, 2012

Doxorubicin Side Effects Report #5841781-X
Doxorubicin side effect was reported by a Health Professional from UNITED STATES on Aug 11, 2008. Male patient, weighting 192.0 lb, was diagnosed with multiple myeloma  and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: epistaxis, haemoglobin decreased, malignant neoplasm progression, multiple myeloma , thrombocytopenia, white blood cell count decreased. Doxorubicin dosage: 31 MG D1 + 8 IV BOLUS. During the same period patient was treated with BORTEZOMIB. Patient recovered.

Doxorubicin Side Effects Report #4741473-4
Doxorubicin side effect was reported by a Consumer or non-health professional from TURKEY on July 22, 2005. Female patient, 23 years of age, was diagnosed with malignant lymphoma unclassifiable high grade and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: accidental overdose, autonomic neuropathy, bone marrow depression, diarrhoea, haematochezia, haemoglobin decreased, hypoaesthesia, hyporeflexia, ileus paralytic. Doxorubicin dosage: 420 MG TOTAL, IV. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #4885856-0
Doxorubicin side effect was reported by a Physician from TURKEY on Jan 05, 2006. Female patient, 23 years of age, was diagnosed with malignant lymphoma unclassifiable high grade and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , autonomic neuropathy, diarrhoea, electrolyte imbalance, gastrointestinal toxicity, haematochezia, haematocrit decreased, haemoglobin decreased, hypocalcaemia. Doxorubicin dosage: 50 MG/M2, ONCE/SINGLE, INTRAVENOUS - SEE IMAGE. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #4956355-2
Doxorubicin side effect was reported by a Physician from FRANCE on Mar 10, 2006. Male patient, 63 years of age, weighting 108.0 lb, was diagnosed with ill-defined disorder and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: c-reactive protein increased, cardiac flutter, febrile bone marrow aplasia, haemoglobin decreased, hyperthermia, leukopenia, neutropenia, platelet count decreased. Doxorubicin dosage: 79 MG (1 IN 1 D), INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, ETOPOSIDE, VERAPAMIL HYDROCHLORIDE, CREON, NEXIUM. Patient was hospitalized. Patient recovered.


Doxorubicin Side Effects Report #4658695-3
Doxorubicin side effect was reported by a Consumer or non-health professional from on May 10, 2005. Female patient, 23 years of age, weighting 121.3 lb, was diagnosed with hodgkin's disease  and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: abdominal pain lower, blood glucose increased, blood potassium decreased, clostridium colitis, dystrophic calcification, fallopian tube disorder, haematocrit decreased, haemoglobin decreased, infarction. Doxorubicin dosage: 25 MG/M2, IV WEEKS 1,3,5,7,9,11. During the same period patient was treated with VINBLASTINE, VINCRISTINE, BLEOMYCIN, MUSTARD, ETOPOSIDE, PREDNISONE, BACTRIM DS, ZANTAC. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #5614869-6
Doxorubicin side effect was reported by a Physician from BRAZIL on Jan 21, 2008. Male patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma stage ii and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase, essential thrombocythaemia, haemoglobin decreased, neutrophil percentage increased. Doxorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, CYCLOPHOSPHAMIDE. Patient recovered.

Doxorubicin Side Effects Report #5008079-3
Doxorubicin side effect was reported by a Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on May 08, 2006. Male patient, 78 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood ph increased, cryptogenic organizing pneumonia, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count increased. Doxorubicin dosage: 84 MG QW IV. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #4582545-7
Doxorubicin side effect was reported by a Health Professional from on Feb 11, 2005. Female patient, 55 years of age, weighting 296.0 lb, was diagnosed with breast cancer  and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: fatigue, haemoglobin decreased, pyrexia, transfusion reaction. Doxorubicin dosage: 60 MG/M2 IV Q 14 DAYS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #4629116-1
Doxorubicin side effect was reported by a Health Professional from on Apr 04, 2005. Female patient, 55 years of age, weighting 296.0 lb, was diagnosed with breast cancer  and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pyrexia, transfusion reaction. Doxorubicin dosage: 60MG/M2 IV 14 DAYS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.


Doxorubicin Side Effects Report #4712964-7
Doxorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2005. Female patient, weighting 146.2 lb, was diagnosed with breast cancer  and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , bacteria stool identified, chills, diarrhoea, fatigue, febrile neutropenia, haemoglobin decreased, hypokalaemia, hypotension. Doxorubicin dosage: 60 MG/M2 IV Q14 DAYS X 4 CYCLES. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.

Doxorubicin Side Effects Report #5324841-1
Doxorubicin side effect was reported by a Physician from SWITZERLAND on May 10, 2007. Female patient, weighting 108.0 lb, was diagnosed with breast cancer metastatic and was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: asthenia, haematotoxicity, haemoglobin decreased, leukopenia, neutropenia, pulmonary embolism . Doxorubicin dosage: unknown. Patient died on 03/07/2006.

Doxorubicin Side Effects Report #5462979-9
Doxorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2007. Female patient, weighting 129.0 lb, was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemodialysis, haemoglobin decreased, herpes simplex , hypotension, platelet count decreased, pneumonia , renal failure acute. Doxorubicin dosage: 62 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, HEPARIN LOCK, LORAZEPAM, LUCENTIS, NORVASC, PRILOSEC, PROCRIT. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #5611925-3
Doxorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2008. Male patient, weighting 173.9 lb, was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: blood culture positive, culture urine positive, escherichia infection, fatigue, haemoglobin decreased, mucosal inflammation, serratia infection, staphylococcal infection , streptococcal infection . Doxorubicin dosage: 80 MG. During the same period patient was treated with GEMCITABINE, TAXOL, NEULASTA. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #5631882-3
Doxorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2008. Male patient, weighting 173.9 lb, was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood potassium increased, blood urea increased, dysphagia, escherichia infection, fatigue, haemoglobin decreased, mucosal inflammation, serratia infection. Doxorubicin dosage: 80 MG. During the same period patient was treated with GEMCITABINE, TAXOL, NEULASTA. Patient was hospitalized. Patient recovered.


Doxorubicin Side Effects Report #5636216-6
Doxorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2008. Male patient, weighting 170.9 lb, was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: bacteria urine, blood creatinine increased, blood potassium increased, blood urea increased, blood urine present, deep vein thrombosis , febrile neutropenia, haemoglobin decreased, hypotension. Doxorubicin dosage: 60 MG. During the same period patient was treated with GEMCITABINE, TAXOL, NEULASTA, LOVENOX, PROTONIX, REGLAN, REMERON, RITALIN. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #5812769-X
Doxorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2008. Male patient, weighting 125.7 lb, was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: ear pain, haemoglobin decreased, hypophagia, neutrophil count decreased, otitis media, platelet count decreased, stomatitis, white blood cell count decreased. Doxorubicin dosage: 103 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #5818743-1
Doxorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2008. Male patient, weighting 40.57 lb, was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , blood potassium decreased, cyanosis, febrile neutropenia, haemoglobin decreased, hallucination, lung infiltration, nausea , tachycardia. Doxorubicin dosage: 37.5 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #6108159-5
Doxorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2009. Female patient, weighting 158.7 lb, was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: fatigue, haemoglobin decreased, tinnitus . Doxorubicin dosage: 53 MG. During the same period patient was treated with TAXOL, NEULASTA. Patient recovered.

Doxorubicin Side Effects Report #4677150-8
Doxorubicin side effect was reported by a Consumer or non-health professional from on May 25, 2005. Female patient, weighting 209.4 lb, was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: haemoglobin decreased, nausea . Doxorubicin dosage: 60 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.


Doxorubicin Side Effects Report #4679260-8
Doxorubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient, weighting 146.2 lb, was treated with Doxorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , chills, diarrhoea, fatigue, febrile neutropenia, haemoglobin decreased, hypotension, pyrexia, sepsis . Doxorubicin dosage: 60 MG/M2 IV Q14 DAYS X 4 CYCLES. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.